Icon

AMMONUL (nda020645)- (10%;10% (5GM/50ML;5GM/50ML))

SODIUM BENZOATE; SODIUM PHENYLACETATE BAUSCH
10%;10% (5GM/50ML;5GM/50ML)
No No
Expired Expired
2012-Feb-17 None
None No
AMMONUL is indicated as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.
3 0 3
Total Other Developers None
Drugs with Suitability Yes
10%;10% (5GM/50ML;5GM/50ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* *** ********** ** **** *************** *********** *** * ***** *** ***** *** ****, **** ****, **** (**) *****, ****** ****** (***) ***
****** **** ****** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.